Swati Mylavarapu
Managing Partner @ Incite.org
San Francisco, United States
Swati Mylavarapu is a Series A investor at Incite.org in San Francisco focused on Health Care and Sensor. Swati Mylavarapu is the Managing Partner at Incite.org and Co-Founder and Board Chair of The Arena. She joined KPCB in 2015 and focuses on venture-stage companies developing digital health and consumer technologies and businesses.Swati joined KPCB from Square, where she was responsible for business operations and strategy for Square’sinternational efforts in Canada and Japan, and led product marketing for Square’s premium software efforts. Prior to Square, she was head of sales and client services at Quid, where she developed the data analytics company’s early revenue model and client base. Swati began her career at Google working on mobile technology efforts in Sub-Saharan Africa and India within Google.org.Swati received an A.B. degree with the highest honors in Development Studies from Harvard University and an MPhil in Economic and Social History from the University of Oxford, where she was a Rhodes Scholar. Swati is also a Truman Scholar, and passionate about the role great technology companies and teams can play in solving important world challenges.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Swati Mylavarapu invests in
Stages Swati Mylavarapu invests in
Countries Swati Mylavarapu invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (40%)
- Sensor 1 (20%)
- FinTech 1 (20%)
- Finance 1 (20%)
- Medical 1 (20%)
Stage
- Series A 4 (80%)
- Seed 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Amulet is shining a light on invisible threats in our food system. Amulet has two core brands: - Allergy Amulet helps consumers determine whether their foods are safe by detecting potentially life-threatening allergenic ingredients. - Amulet Scientific equips businesses and manufacturers with tools to help ensure the safety of their food supplychain. Learn more: www.allergyamulet.com www.amuletscientific.com | $5.8M / Series A / Aug 12, 2024 | ||
| Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds. Whether it’s on a keychain, a necklace, a wristband, or in a pocket, Allergy Amulet’s sleek and portable design allows users to savor life’s important moments, safely and simply. Food allergies affect 32 millionAmericans and between 220-520 million people globally. That’s 1 in 13 children and 1 in 10 adults. Allergy Amulet has the potential to improve the quality of life for the millions of people living with food allergies or intolerances. | $5.8M / Series A / Aug 12, 2024 | ||
| Aigen is connecting farmers to breakthrough technologies, decarbonizing agriculture, and improving human and planetary health. The company is developing an autonomous, solar-powered robotics platform that manages plants without the chemical inputs that undermine soil's carbon storage potential by bringing alternatives to conventionalpractices, allowing farmers to regenerate soil health and deal with the global agriculture manual labor shortage. | $12M / Series A / Oct 12, 2023 | ||
| ANA Therapeutics is a developer of a novel coronavirus vaccine intended to save human lives. It is developing therapeutics to solve the coronavirus pandemic using Niclosamide that enables medical practitioners to treat patients suffering from COVID-19. It was founded in 2020 and is headquartered in Foster City, California. | $5M / Seed / Aug 04, 2020 | ||
| Nav is a free site and app that gives business owners the fastest, easiest and most trusted path to financing. The leading Business Financial Management app, Nav gives free access to personal and business credit reports from major consumer and commercial credit bureaus including Experian, Dun & Bradstreet, Equifax and TransUnion, and hosts arobust marketplace with more than 100 business financing products including loans and credit cards. The marketplace uses a unique, lender-neutral approach to help business owners find the best financing options for their needs. Nav's solution is also leveraged by other business service providers to enhance their customer experience. | $15.7M / Series A / Nov 28, 2015 |
Co-Investors
Great Oaks Venture Capital
2 deals together
HealthX Ventures
2 deals together
Mendota Venture Capital
2 deals together
SOSV
2 deals together
Album VC
1 deal together
About Incite.org
Incite.org is an organization started by Matt Rogers and Swati Mylavarapu to support new, world-improving ideas, leaders, and teams. Incite is comprised of three branches, each of which has its own area of focus:Incite Ventures, LLC supports mission-driven enterprise through investments in businesses with the potential to scale, inspire others,and make a difference.Incite Labs is a 501(c)(3) nonprofit organization that makes grants and program-related investments to further charitable, educational, and scientific purposes.Incite Politics is the name of the work of Incite’s founders, Swati Mylavarapu and Matt Rogers, to personally organize and support initiatives to pass legislation and elect candidates who approach our country’s issues from a fresh perspective.
Incite.org Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Matt Rogers
Founder
|
|||
|
Swati Mylavarapu
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Swati Mylavarapu invest in?
Swati Mylavarapu invests primarily in Health Care, Sensor and FinTech startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Swati Mylavarapu?
Public channels for Swati Mylavarapu include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Swati Mylavarapu last invest?
The most recent investment recorded for Swati Mylavarapu closed in Aug 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
